Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment [NA]

View source ↗

Summary

This document provides an update on an ongoing clinical trial evaluating the effects of vitamin D and folic acid on mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)
  • folic acid (folic acid)

Snippet

Sponsor: Capital Medical University | Conditions: Mild Cognitive Impairment | NA | Status: ACTIVE_NOT_RECRUITING